Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

NCT01074268 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
456
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S